Reduced expression of MTUs1 mRNA is correlated with poor prognosis in bladder cancer

Oncology Letters

Volumn 4, Issue 1, 2012, Pages 113-118

  Xiao, Jun ^a   Chen, Jun Xing ^b   Zhu, Yu Ping ^a   Zhou, Lin Yu ^a   Shu, Qi An ^a   Chen, Ling Wu ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bladder cancer; Mitochondrial tumor suppressor 1; Prognosis; Survival

Indexed keywords

MESSENGER RNA; MITOCHONDRIAL TUMOR SUPPRESSOR 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84861304588     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.673     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Ploeg M, Aben KK and Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol 27: 289-293, 2009.
3. Lei T, Mao WM, Yang HJ, et al: Study on cancer incidence through the Cancer Registry Program in 11 cities and counties, China. Zhonghua Liu Xing Bing Xue Za Zhi 30: 1165-1170, 2009 (In Chinese).
4. Jacobs BL, Lee CT and Montie JE: Bladder cancer in 2010: how far have we come? CA Cancer J Clin 60: 244-272, 2010.
5. Seibold S, Rudroff C, Weber M, Galle J, Wanner C and Marx M: Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J 17: 1180-1182, 2003.
6. Pils D, Horak P, Gleiss A, et al: Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer 104: 2417-2429, 2005.
7. Dexter TJ, Sims D, Mitsopoulos C, Mackay A, Grigoriadis A, Ahmad AS and Zvelebil M: Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer. BMC Syst Biol 4: 127, 2010.
8. Sayagués JM, Abad Mdel M, Melchor HB, et al: Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis. J Pathol 221: 308-319, 2010.
9. Fong Y, Lin YS, Liou CP, Li CF and Tzeng CC: Chromosomal imbalances in lung adenocarcinomas with or without mutations in the epidermal growth factor receptor gene. Respirology 15: 700-705, 2010.
10. Califano D, Pignata S, Pisano C, et al: FEZ1/LZTS1 protein expression in ovarian cancer. J Cell Physiol 222: 382-386, 2010.
11. Cheng L, MacLennan GT, Zhang S, et al: Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin Cancer Res 14: 8087-8093, 2008.
12. Kim JW, Cheng Y, Liu W, et al: Genetic and epigenetic inactivation of LPL gene in human prostate cancer. Int J Cancer 124: 734-738, 2009.
13. Knowles MA, Aveyard JS, Taylor CF, Harnden P and Bass S: Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer. Cancer Lett 225: 121-130, 2005.
14. Di Benedetto M, Bièche I, Deshayes F, et al: Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 380: 127-136, 2006.
15. Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, et al: 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS One 4: e7239, 2009.
16. Stoll M and Unger T: Angiotensin and its AT2 receptor: new insights into an old system. Regul Pept 99: 175-182, 2001.
17. Lee S, Bang S, Song K and Lee I: Differential expression in normal-adenomacarcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16: 747-754, 2006.
18. Ye H, Pungpravat N, Huang BL, et al: Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma. Cancer Genet Cytogenet 176: 100-106, 2007.
19. Frank B, Bermejo JL, Hemminki K, et al: Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 28: 1442-1445, 2007.
20. Zuern C, Heimrich J, Kaufmann R, et al: Down-regulation of MTUS1 in human colon tumors. Oncol Rep 23: 183-189, 2010.
21. Nouet S, Amzallag N, Li JM, et al: Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 279: 28989-28997, 2004.
22. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med 10: 789-799, 2004.
23. Meloche S and Pouysségur J: The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227-3239, 2007.